CHARLES M BAUM
CIK 1579824 · Founder, President, and CEO · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.9K
Companies
5
Total Filings
71
Lifetime Open-Market Net
-$47.82M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMVP | Director | — | $1.11 | — | $0 | 7 | 2026-06-05 |
| ACRV | Director | 9,366 | $1.48 | $13.9K | $0 | 4 | 2026-05-20 |
| Poseida Therapeutics, Inc. (PSTX) Delisted | Director | 0 | $9.50 | $0 | $0 | 4 | 2025-01-08 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Founder, President, and CEO | 114,482 | $58.70 | $6.72M | -$47.82M | 42 | 2024-01-23 |
| IMMUNOMEDICS INC (IMMU) Delisted | Director | 0 | — | — | $0 | 4 | 2020-10-23 |
Recent Filings · Page 2 of 8
71 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-10 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +54,054 | $2.00M | EDGAR |
| 2023-06-28 | ACRV | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | +19,650 | $0 | EDGAR |
| 2023-06-12 | PMVP | Grant (A) | — | $0 | EDGAR |
| 2023-01-24 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +4,444 | $0 | EDGAR |
| 2023-01-05 | Mirati Therapeutics, Inc. (MRTX) Delisted | Sell (S) | −3,648 | -$170.0K | EDGAR |
| 2022-12-21 | Mirati Therapeutics, Inc. (MRTX) Delisted | Mixed | +44,526 | -$367.5K | EDGAR |
| 2022-11-28 | Mirati Therapeutics, Inc. (MRTX) Delisted | Mixed | — | -$5.72M | EDGAR |
| 2022-06-16 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | +39,300 | $0 | EDGAR |
| 2022-06-06 | PMVP | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.